Efficacy and Safety Study of Zinc Acetate to Treat Wilson's Disease in Japan.

Phase3,Open-label,Clinical Trial of Zinc Acetate for Treatment of Wilson's Disease in Japan.

Status

Completed

Phases

Phase 3

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00212368

Enrollment

Unknown

Registered

2005-09-21

Start date

2004-10-31

Completion date

2005-12-31

Last updated

2010-09-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Wison's Disease

Brief summary

The purpose of this study is to determine whether Zinc Acetate is effective and safe in the treatment of Wilson's disease among Japanese.

Interventions

DRUGZinc acetate

Study design

Allocation

NON_RANDOMIZED

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

1 Years to No maximum

Healthy volunteers

Inclusion criteria

* Wilson's disease(adult,infant,pregnant woman)

Exclusion criteria

* acute hepatitis * malignant tumor

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026